Drug Shortage Report for MYLAN-TOLTERODINE ER

Last updated on 2022-02-15 History
Report ID 17787
Drug Identification Number 02404184
Brand name MYLAN-TOLTERODINE ER
Common or Proper name TOLTERODINE ER
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) TOLTERODINE TARTRATE
Strength(s) 2MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL
Packaging size 100BT, 30BT
ATC code G04BD
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-10-10
Actual start date 2017-10-10
Estimated end date Unknown
Actual end date 2022-02-14
Shortage status Resolved
Updated date 2022-02-15
Company comments Last lot 3079138, Expiry August-31-2018
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v60 2022-02-15 French Compare
v59 2022-02-15 English Compare
v58 2020-01-14 French Compare
v57 2020-01-14 English Compare
v56 2019-02-21 French Compare
v55 2019-02-21 English Compare
v54 2018-11-06 French Compare
v53 2018-11-06 English Compare
v52 2018-10-03 French Compare
v51 2018-10-03 English Compare
v50 2018-08-28 French Compare
v49 2018-08-28 English Compare
v48 2018-08-28 French Compare
v47 2018-08-28 English Compare
v46 2018-07-25 French Compare
v45 2018-07-25 English Compare
v44 2018-05-23 French Compare
v43 2018-05-23 English Compare
v42 2018-05-18 French Compare
v41 2018-05-18 English Compare

Showing 1 to 20 of 60